Therapeutic Area | MeSH |
---|---|
mental disorders | D001523 |
Brand Name | Status | Last Update |
---|---|---|
alprazolam | ANDA | 2027-07-31 |
alprazolam c-iv | ANDA | 2025-01-22 |
alprazolam intensol | 2006-01-04 | |
alprazolam xr | NDA authorized generic | 2011-04-12 |
gabazolamine | unapproved drug other | 2011-08-18 |
gabazolamine-0.5 | unapproved drug other | 2011-08-01 |
niravam | New Drug Application | 2011-04-19 |
sentrazolam am | unapproved drug other | 2011-08-01 |
xanax | New Drug Application | 2023-04-12 |
xanax xr | New Drug Application | 2010-04-20 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Anxiety | D001007 | EFO_0005230 | F41.1 | 2 | — | — | — | — | 2 |
Drug common name | Alprazolam |
INN | alprazolam |
Description | Alprazolam is a member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug. It has a role as an anxiolytic drug, an anticonvulsant, a muscle relaxant, a sedative, a GABA agonist and a xenobiotic. It is a triazolobenzodiazepine and an organochlorine compound. |
Classification | Small molecule |
Drug class | Benzodiazepine |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2 |
PDB | — |
CAS-ID | 28981-97-7 |
RxCUI | — |
ChEMBL ID | CHEMBL661 |
ChEBI ID | 2611 |
PubChem CID | 2118 |
DrugBank | DB00404 |
UNII ID | YU55MQ3IZY (ChemIDplus, GSRS) |